Levetiracetam for seizures after liver transplantation

被引:24
作者
Glass, GA
Stankiewicz, J
Mithoefer, A
Bergethon, PR
机构
[1] Tufts Univ, New England Med Ctr, Dept Neurol, Boston, MA 02111 USA
[2] Tufts Univ, New England Med Ctr, Dept Surg, Boston, MA 02111 USA
关键词
D O I
10.1212/01.WNL.0000154598.03596.40
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Seizures may occur after orthotopic liver transplantation. Antiepileptic drugs (AEDs) are used to treat these seizures, but the immunosuppressant regimen also may be altered. Levetiracetam is an attractive treatment because of its efficacy, lack of hepatic enzyme induction, and its rapid attainment of serum levels. Treatment with levetiracetam is efficacious, and levetiracetam-treated patients require significantly lower doses of immunosuppressant medications to achieve an equivalent antirejection effect.
引用
收藏
页码:1084 / 1085
页数:2
相关论文
共 10 条
[1]   Central nervous system complications in liver transplant recipients - incidence, timing, and long-term follow-up [J].
Bronster, DJ ;
Emre, S ;
Boccagni, P ;
Sheiner, PA ;
Schwartz, ME ;
Miller, CM .
CLINICAL TRANSPLANTATION, 2000, 14 (01) :1-7
[2]   Levetiracetarn monotherapy for liver transplant patients with seizures [J].
Chabolla, DR ;
Harnois, DM ;
Meschia, JF .
TRANSPLANTATION PROCEEDINGS, 2003, 35 (04) :1480-1481
[3]   The new antiepileptic drugs - Scientific review [J].
LaRoche, SM ;
Helmers, SL .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (05) :605-614
[4]   Neurologic complications of liver transplantation in adults [J].
Lewis, MB ;
Howdle, PD .
NEUROLOGY, 2003, 61 (09) :1174-1178
[5]   Clinical pharmacokinetics of sirolimus [J].
Mahalati, K ;
Kahan, BD .
CLINICAL PHARMACOKINETICS, 2001, 40 (08) :573-585
[6]   CLINICAL PHARMACOKINETICS OF CYCLOSPORINE [J].
PTACHCINSKI, RJ ;
VENKATARAMANAN, R ;
BURCKART, GJ .
CLINICAL PHARMACOKINETICS, 1986, 11 (02) :107-132
[7]  
UNDRE NA, 1999, TRANSPL P, V31, P21
[8]  
Welty TE, 2002, ANN PHARMACOTHER, V36, P296
[9]   Causes and outcome of seizures in liver transplant recipients [J].
Wijdicks, EFM ;
Plevak, DJ ;
Wiesner, RH ;
Steers, JL .
NEUROLOGY, 1996, 47 (06) :1523-1525
[10]   Buffering effect of religiosity for adolescent substance use [J].
Wills, TA ;
Yaeger, AM ;
Sandy, JM .
PSYCHOLOGY OF ADDICTIVE BEHAVIORS, 2003, 17 (01) :24-31